PKD1 and Hypomagnesemia: To test if increased pannexin‐1 activity underlies the hypocalcemia and hypomagnesemia observed in iKsp‐Pkd1−/− mice, mice were treated with the pannexin‐1 inhibitor BB‐FCF for 26 days.